MM
Mary K Moreland
Executive Vice President

Mary K Moreland insider trades: Abbott Laboratories (ABT) stock sales

Executive Vice President, Abbott Laboratories Last trade Nov 5, 2026 20 Form 4 filings
$406K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2020
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mary reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026ABT↓ Sell$406K
Mar 3, 2025ABT↓ Sell$109K
Mar 1, 2024ABT↓ Sell$80K
Mar 1, 2023ABT↓ Sell$72K
Feb 22, 2021ABT↓ Sell$48K
Feb 22, 2021ABT↓ Sell$49K
Feb 16, 2021ABT↓ Sell$65K
Feb 25, 2020ABT↓ Sell$34K
Feb 19, 2020ABT↓ Sell$91K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ABT insiders

Open-market trades in the last 12 months

About Mary K Moreland's insider trades

Mary K Moreland is Executive Vice President at Abbott Laboratories (ABT). Since Feb 19, 2020, Mary has reported no open-market purchases and 9 sales worth $954K on SEC Form 4. In the last 12 months: 1 sale ($406K).

Their filings also include shares withheld for taxes (13 filings), grants and awards (8 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.